LPS is also a known inducer of the mitogen activated protein kinase (MAPK) pathway which enhances cellular proliferation in response to interleukin-1 (IL-1), another oncogenic factor for NPC [51]. The gene discussed is IL1B; the disease is nasopharyngeal carcinoma.